Journal of Surgery Concepts & Practice ›› 2019, Vol. 24 ›› Issue (01): 6-9.doi: 10.16139/j.1007-9610.2019.01.002
• Experts forum • Previous Articles Next Articles
Received:
2018-11-26
Online:
2019-01-25
Published:
2019-02-25
CLC Number:
[1] Torre LA, Bray F, Siegel R, et al.Global cancer statistics, 2012: Global Cancer Statistics, 2012[J]. CA Cancer J Clin,2015,65(2):87-108. [2] Eto K, Hiki N, Kumagai K, et al.Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications[J]. Gastric Cancer,2018,21(4):703-709. [3] van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preo-perative chemoradiotherapy for esophageal or junctional cancer[J]. N Engl J Med,2012,366(22):2074-2084. [4] Miller AB, Hoogstraten B, Staquet M, et al.Reporting results of cancer treatment[J]. Cancer,1981,47(1):207-214. [5] Watanabe H, Okada M, Kaji Y, et al.New response eva-luation criteria in solid tumours: Revised RECIST guideline (version 1.1)[J]. Gan to Kagaku Ryoho,2009, 36(13):2495-2501. [6] Choi H, Charnsangavej C, Faria SC, et al.Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria[J]. J Clin Oncol,2007,25(13):1753-1759. [7] Kurokawa Y, Shibata T, Sasako M, et al.Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer(JCOG0507-A)[J]. Gastric Cancer,2014,17(3):514-521. [8] Liu K, Li G, Fan C, et al.Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy[J]. Acta Radiol,2012,53(2):127-134. [9] Park SR, Lee JS, Chan GK, et al.Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer[J]. Cancer,2008, 112(11):2368-2376. [10] Gao X, Zhang Y, Yuan F, et al.Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy[J]. J Cancer Res Clin Oncol,2018,144(11):2207-2218. [11] Luo Y, Chen J, Huang K, et al.Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?[J]. BMC Cancer,2017,17(1):154. [12] Smith AD, Zhang X, Bryan J, et al.Vascular tumor burden as a new quantitative CT biomarker for predicting metastatic RCC response to antiangiogenic therapy[J]. Radiology,2016,281(2):484-498. [13] Thian Y, Gutzeit A, Koh DM, et al.Revised Choi ima-ging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib[J]. Radiology,2014,273(2):452-461. [14] Rombolà F, Caravetta A, Mollo F, et al.Sorafenib, risk of bleeding and spontaneous rupture of hepatocellular carcinoma. A clinical case[J]. Acta Medica (Hradec Kralove),2011,54(4):177-179. [15] Di Fabio F, Pinto C, Rojas Llimpe FL, et al.The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab[J]. Gastric Cancer,2007, 10(4):221-227. [16] Mesenas S, Vu C, Mcstay M, et al.A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy[J]. Dis Esophagus,2010,21(1):37-42. [17] Yoshikawa T, Tanabe K, Nishikawa K, et al. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase Ⅱ study[J]. Ann Surg Oncol,2014,21 Suppl 3:S385-S389. [18] 申屠伟慧, 黄品同, 鄢曹鑫, 等. 超声双重造影在进展期胃癌新辅助化疗疗效评价中的价值[J]. 中华超声影像学杂志,2016,25(3):212-217. [19] 谭艳娟, 黄品同, 黄安茜, 等. 超声双重造影在进展期胃癌新辅助化疗后T分期及疗效评价中的价值[J]. 中华超声影像学杂志,2012,21(7):587-590. [20] Kruk-Bachonko J, Krupski W, Czechowski M, et al.Perfusion CT-A novel quantitative and qualitative imaging biomarker in gastric cancer[J]. Eur J Radiol,2017,95:399-408. [21] Lee SM, Kim SH, Lee JM, et al.Usefulness of CT vo-lumetry for primary gastric lesions in predicting patholo-gic response to neoadjuvant chemotherapy in advanced gastric cancer[J]. Abdom Imaging,2009,34(4):430-440. [22] Chen XH, Ren K, Liang P, et al.Spectral computed tomography in advanced gastric cancer: Can iodine concentration non-invasively assess angiogenesis?[J]. World J Gastroenterol,2017,23(9):1666-1675. [23] Tang L, Li ZY, Li ZW, et al.Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression[J]. Clin Radiol,2015,70(11):1198-1204. [24] 张阳, 张欢, 闫静, 等. 双源双能量CT碘值在评估进展期胃腺癌新辅助化疗疗效中的价值[J]. 诊断学理论与实践,2018,17(2):191-196. [25] Giganti F, Orsenigo E, Esposito A, et al.Prognostic role of diffusion-weighted MR imaging for resectable gastric cancer[J]. Radiology,2015,276(2):444-452. [26] Lee DH, Kim SH, Im SA, et al.Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study[J]. Eur Radiol,2016,26(8):2771-2778. [27] Giganti F, De Cobelli F, Canevari C, et al.Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume correc-ted standardized uptake value with histological tumor regression grade[J]. J Magn Reson Imaging,2014,40(5):1147-1157. [28] Schneider PM, Eshmuminov D, Rordorf T, et al.18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study[J]. BMC Cancer,2018, 18(1):548. [29] Park S, Ha S, Kwon HW, et al.Prospective evaluation of changes in tumor size and tumor metabolism in patients with advanced gastric cancer undergoing chemotherapy: association and clinical implication[J]. J Nucl Med,2017,58(6):899-904. [30] Smyth E, Schöder H, Strong VE, et al.A prospective eva-luation of the utility of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer[J]. Cancer,2012,118(22):5481-5488. [31] Chen R, Zhou X, Liu J, et al.Relationship between 18F-FDG PET-CT scans and HER2 expression in gastric cancer[J]. J Nucl Med,2016,57(7):1040-1044. [32] Lee JW, Jo K, Cho A, et al.Relationship between 18F-FDG uptake on PET and recurrence patterns after curative surgical resection in patients with advanced gastric cancer[J]. J Nucl Med,2015,56(10):1494-1500. |
[1] | DAI Zhiqiang, ZHENG Jinxin, TANG Zhaoqing, ZHANG Qi, GU Yuan, SHI Zhongyi, HU Guohua, SUN Yihong. Metastatic lymph node ratio to evaluate prognosis of patients with stage Ⅱ-Ⅲ gastric cancer after radical gastrectomy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 429-434. |
[2] | NIE Mingming, ZHU Zhenggang. Clinical significance of diagnostic laparoscopy on precision staging in advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 365-370. |
[3] | GUO Liangqi, YAN Zhilong, ZHANG Moucheng. Laparoscopic intragastric surgery in treating of gastric submucosal tumor and early gastric cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 380-383. |
[4] | LU Weihui, LIU Wei, WANG Cong, WANG Zhenglin. Effects of CXCR2 on invasion, migration and apoptosis of gastric cancer cells [J]. Journal of Surgery Concepts & Practice, 2021, 26(5): 430-436. |
[5] | LIU Jingzheng, REN Zhong, HU Jianwei, QIN Wenzheng, ZHONG Yunshi, ZHOU Pinghong. Clinical effect of endoscopic full thickness resection in treatment of small gastric submucosal tumors [J]. Journal of Surgery Concepts & Practice, 2021, 26(03): 236-239. |
[6] | . [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 1-6. |
[7] | . [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 11-16. |
[8] | . [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 17-20. |
[9] | . [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 28-33. |
[10] | . [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 38-40. |
[11] | YANG Zhongyin, LI Chen, LIU Wentao, SHI Min, WU Junwei, ZHENG Yanan, ZHU Zhenglun, HUA Zichen, NI Zhentian, LU Sheng, YAN Min, YAN Chao, ZHU Zhenggang. Complications of implanted subcutaneous port for intraperitoneal chemotherapy in gastric cancer patients with peritoneal metastasis and analysis of risk factors of complications [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 41-47. |
[12] | LI Mei, QIU Wencai, GAO Qi, YANG Jun, JIA Zhenyi. Perioperative application of geriatric nutritional risk index in senile patients with gastrointestinal tumors [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 58-61. |
[13] | . [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 76-78. |
[14] | . [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 79-83. |
[15] | . [J]. Journal of Surgery Concepts & Practice, 2020, 25(04): 341-343. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||